| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 07/15/2004 | WO2004050621A3 Indol derivatives and their use as kinase inhibitors |
| 07/15/2004 | WO2004047772A3 Catalytic antioxidants and methods of use |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004043900A3 4-alkyl/4-alkenyl/4-alkynyl methyl/-1-arylcyclohexylamine derivatives |
| 07/15/2004 | WO2004035736A3 Halogenated selective androgen receptor modulators and methods of use thereof |
| 07/15/2004 | WO2004031129A3 Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| 07/15/2004 | WO2004027078A3 Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions |
| 07/15/2004 | WO2003092626A3 Carvedilol pharmasolve solvate |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | US20040138468 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/15/2004 | US20040138462 Aminoalcohol derivatives |
| 07/15/2004 | US20040138304 Prodrugs of excitatory amino acids |
| 07/15/2004 | US20040138287 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 07/15/2004 | US20040138284 Indol-3-yl derivatives |
| 07/15/2004 | US20040138283 Deep vein thrombosis, noninsulin dependent diabetes, atherosclerosis, and pulmonary fibrosis treatment; cardiovascular and brain disorders |
| 07/15/2004 | US20040138282 Agents useful for reducing amyloid precursor protein and treating demantia and methods of use thereof |
| 07/15/2004 | US20040138272 Central nervous system disorders; anticancer agents; antiproliferative agents |
| 07/15/2004 | US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138246 Benz-indole and benzo-quinoline derivatives as prodrugs for tumor treatment |
| 07/15/2004 | US20040138227 Antiserotonine agents; antidepressants |
| 07/15/2004 | US20040138205 Viricides; hepatitis virus |
| 07/15/2004 | US20040138203 Antiserotonine agents |
| 07/15/2004 | US20040138197 Therapeutic use of aryl amino acid derivatives |
| 07/15/2004 | US20040138195 Activation using enzyme or ionizing radiation |
| 07/15/2004 | US20040138183 Bactericides; anticarcinogenic agents; modulation of gene expression; therapy for antibiotic resistant bacteria |
| 07/15/2004 | US20040137273 Red color emitting compounds for organic electroluminescent device and an organic electroluminescent device using them |
| 07/15/2004 | US20040137262 ELECTROLUMINESCENT MULTILAYER COMPRISING CATHODE, ANODE AND ORGANIC LAYER; two indole-based structure connecting by an arylamine |
| 07/15/2004 | DE10300099A1 Indol-Phenylsulfonamid-Derivate Indole derivatives phenylsulfonamide |
| 07/15/2004 | DE10300015A1 Iminosäurederivate als Inhibitoren von Matrix-Metallproteinasen Iminosäurederivate as inhibitors of matrix metalloproteinases |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1437132A1 Use of nitric ester derivatives in the manufacture of a medicament for the treatment of gastrointestinal tumors |
| 07/14/2004 | EP1437131A1 Use of an ACE inhibitor for the prevention of diabetes in a patient with no preexisting congestive heart failure |
| 07/14/2004 | EP1436273A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 07/14/2004 | EP1436267A1 Lactam derivatives as antagonists for human 11cby receptors |
| 07/14/2004 | EP1436261A1 Method for preparing n-($g(v)-bromoalkyl)phthalimides |
| 07/14/2004 | EP1436260A1 Method for preparing n-(v)-bromoalkyl)phthalimides |
| 07/14/2004 | EP1436259A1 3-(4,5,6,7-tetrahydroindol-2-ylmethylidiene)-2-indolinone derivatives as kinase inhibitors |
| 07/14/2004 | EP1435964A2 Novel prodrugs of n-h bond-containing compounds and methods of making thereof |
| 07/14/2004 | EP1435956A2 Therapeutic combinations for cardiovascular and inflammatory indications |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435782A1 Treatment for cystic fibrosis |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP1056721B1 Method for purifying (+-)-2-azabicyclo(2.2.1)hept-5-en-3-one |
| 07/14/2004 | CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer |
| 07/14/2004 | CN1513171A Optical data carrier containing dye in the information layer as light-absorbing compound |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1512880A Novel compounds and compositions as cathepsin inhibitors |
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/14/2004 | CN1157375C Indole Ferivatives and medicinal compositions containing same |
| 07/14/2004 | CN1157188C Method for inhibiting stress-activated protein kinases |
| 07/14/2004 | CN1157115C Antifungal active compound compsns. |
| 07/13/2004 | US6762326 C2-substituted idan-1-ones and their derivatives, processes for their preparation and their use as pharmaceuticals |
| 07/13/2004 | US6762204 Taxol enhancer compounds |
| 07/13/2004 | US6762201 Such as n-((2-amino-5-(n-methyl-n-((1-methylindol-2-yl) -methyl)carbamoyl)phenyl)methyl)-n-methylacetamide; bacterial infections |
| 07/13/2004 | US6762180 Substituted indolines which inhibit receptor tyrosine kinases |
| 07/13/2004 | US6762152 Four to seven membered heterocycles substituted on benzene ring; reaction of a ketone with a substituted benzoic acid |
| 07/13/2004 | US6762048 System and apparatus for nucleic acid sequencing of single molecules by polymerase synthesis |
| 07/13/2004 | US6761878 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 07/08/2004 | WO2004056784A1 Novel carboxamides, the production and use thereof as medicaments |
| 07/08/2004 | WO2004056777A1 Microsomal triglyceride transfer protein inhibitors |
| 07/08/2004 | WO2004056769A2 Synthesis of amines and intermediates for the synthesis thereof |
| 07/08/2004 | WO2004056755A2 Compounds for the inhibition of non-proteolytic enzymes |
| 07/08/2004 | WO2004056745A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056744A1 Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056727A2 Process of making chalcone derivatives |
| 07/08/2004 | WO2004056361A1 4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents |
| 07/08/2004 | WO2004009017A3 Modulators of the glucocorticoid receptor and method |
| 07/08/2004 | WO2004003031A3 Polymerization catalyst activators, method of preparing and their use in polymerization processes |
| 07/08/2004 | WO2003097598A8 Compound exhibiting pgd 2 receptor antagonism |
| 07/08/2004 | US20040133014 Reacting thiols with N-chlorosuccinimide to produce sulfenyl chlorides in situ that readily react with indole 2-carboxylates to give 3-thioindoles in high yields |
| 07/08/2004 | US20040133012 For use as anesthetics and as neuroprotective agents; prevents the formation of the toxic metabolite, 2-phenyl-acrylamide |
| 07/08/2004 | US20040133008 Amide compounds |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132800 aminomethyl- or ethyl-substituted indoles, tetrahydrocarbazoles and tetrahydropyrido[1,2-a]indoles |
| 07/08/2004 | US20040132799 Aminoalkoxyindoles and methods of use |
| 07/08/2004 | US20040132797 treating of or preventing relapse of depression, anxiety disorders, eating disorders, or urinary incontinence |
| 07/08/2004 | US20040132783 Method of examining effect of angiogenesis inhibitors mediated by the inhibition of integrin expression |
| 07/08/2004 | US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
| 07/08/2004 | US20040132752 cyclic ureas and triazolones; treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia. |
| 07/08/2004 | US20040132750 Acyl guanidine compounds and use thereof |
| 07/08/2004 | US20040132745 carbamoyl-substituted aromatics, e.g., N-(butylcarbamoyl-phenyl-methyl)-6-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-nicotinamide; treating hypercholesterolemia, hypertriglyceridemia, pancreatitis, obesity and diabetic conditions |
| 07/08/2004 | US20040132741 N-sulfonylindoles and N-sulfonylindazoles; treating motor disorders, anxiety disorders or cognitive disorders, such as schizophrenia, depression, Alzheimer's disease or Parkinson's disease |
| 07/08/2004 | US20040132715 Method to treat allergic rhinitis |
| 07/08/2004 | US20040131969 Non-resonant two-photon absorbing material, non-resonant two-photon emitting material, method for inducing absorption of non-resonant two-photons and method for generating emission of non-resonant two-photons |
| 07/08/2004 | US20040131885 Organic electroluminescent device and organic electroluminescent compound thereof |
| 07/08/2004 | CA2510846A1 New carboxylic acid amides,the preparation thereof and their use as pharmaceutical compositions |
| 07/08/2004 | CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | CA2508290A1 Synthesis of amines and intermediates for the synthesis thereof |
| 07/08/2004 | CA2508275A1 4-(1-(sulfonyl)-1h-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as therapeutic agents |
| 07/08/2004 | CA2505604A1 Microsomal triglyceride transfer protein inhibitors |
| 07/07/2004 | EP1435384A2 Red light emitting compounds for organic electroluminescent devices and organic electroluminescent devices using them |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/07/2004 | EP1434584A2 Compositions and methods of treatment of cancer |
| 07/07/2004 | EP1434578A1 Arylsulphonyl-substituted tetrahydro- and hexahydro-carbazoles as 5-ht-6 receptor ligands |
| 07/07/2004 | CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives |
| 07/07/2004 | CN1156834C 光学记录介质 The optical recording medium |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156447C process for preparation of spiro-[cis-4(beta-hydroxyethyloxy)cyclohexane-(3H)indol]-2'[1,H]-one derivs |
| 07/07/2004 | CN1156446C Indenoindolone compounds, their preparation and medicinal compositions containing them |
| 07/07/2004 | CN1156445C Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isindoline derivatives |